PHF3
Summary: This gene encodes a member of a PHD finger-containing gene family. This gene may function as a transcription factor and may be involved in glioblastomas development. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Mar 2014].
Name | OMIM ID | Ensembl ID | HGNC ID | PHARMGKB ID | Map Location |
---|---|---|---|---|---|
PHD finger protein 3 | MIM:607789 | Ensembl:ENSG00000118482 | HGNC:HGNC:8921 | PA33261 | 6q12 |
GO terms in PHF3
Term Type | Evidence Type | GO Term ID | GO Des. |
---|---|---|---|
MF | ND | GO:0003674 | molecular_function |
MF | IEA | GO:0046872 | metal ion binding |
BP | IEA | GO:0006351 | transcription, DNA-templated |
BP | NAS | GO:0007275 | multicellular organism development |
CC | ND | GO:0005575 | cellular_component |
Gene expression in normal tissue: PHF3
Gene-model tissue-cancer distribution: Bubble Plot
Gene-drug pathway distribution
Pathways in PHF3
Database | Pathway ID | Pathway Des. |
---|
Gene-Drug: Aster Plot
Drug ID | Drug Name | Model Num. |
---|---|---|
iGMDRD227 | Fatostatin A | 1 |
iGMDRD103 | SN-38 | 6 |
iGMDRD137 | Indisulam | 2 |
iGMDRD121 | GMX1778 | 3 |
iGMDRD202 | Curcumin | 2 |
iGMDRD77 | Itraconazole | 2 |
iGMDRD267 | Oligomycin A | 2 |
iGMDRD705 | Nakiterpiosin | 3 |
iGMDRD289 | Parthenolide | 4 |
iGMDRD434 | BMS-536924 | 1 |
iGMDRD329 | Merck60 | 3 |
iGMDRD662 | JQ-1 | 3 |
iGMDRD366 | PI-103 | 1 |
iGMDRD286 | Nsc 632839 | 2 |
iGMDRD871 | BRD6368 | 7 |
iGMDRD872 | BRD7137 | 2 |
iGMDRD82 | Quiflapon | 3 |
iGMDRD300 | Tozasertib | 4 |
iGMDRD886 | Compound 1541A | 8 |
iGMDRD246 | NPC26 | 2 |
iGMDRD84 | Lovastatin acid | 3 |
iGMDRD330 | BRD4132 | 3 |
iGMDRD523 | Cyanoquinoline, 11 | 3 |
iGMDRD79 | Gemcitabine | 3 |
iGMDRD116 | CD437 | 3 |
iGMDRD424 | Tamatinib | 5 |
iGMDRD345 | Compound 10b [PMID: 11504634] | 3 |
iGMDRD351 | GW843682X | 2 |
iGMDRD219 | Bax channel blocker | 2 |
iGMDRD237 | ABT-751 | 1 |
iGMDRD341 | Triacsin c | 3 |
iGMDRD132 | (-)-gallocatechin-3-O-gallate | 3 |
iGMDRD945 | ML214 | 1 |
iGMDRD211 | (1S,3R)-RSL3 | 2 |
iGMDRD260 | FQI-2 | 5 |
iGMDRD255 | SB225002 | 2 |
iGMDRD138 | PX 12 | 6 |
iGMDRD885 | Compound 110 | 3 |
iGMDRD318 | PAC-1 | 8 |
iGMDRD506 | Fedratinib | 8 |
iGMDRD780 | PP-30 | 4 |
iGMDRD100 | Zebularine | 1 |
iGMDRD188 | Piperlongumine | 5 |
iGMDRD887 | Compound 23 citrate | 3 |
iGMDRD74 | Idarubicin | 2 |
iGMDRD399 | Selumetinib | 3 |
iGMDRD23 | Gossypol | 5 |
iGMDRD772 | BRD4770 | 2 |
iGMDRD420 | Leucascandrolide A | 3 |
iGMDRD126 | Tipifarnib | 2 |
iGMDRD151 | CHM-1 | 5 |
iGMDRD433 | Lexibulin | 3 |
iGMDRD494 | Neopeltolide | 2 |
iGMDRD670 | ML 210 | 3 |
iGMDRD779 | PRL-3 Inhibitor I | 6 |
iGMDRD152 | 179324-69-7 | 3 |
iGMDRD61 | Kinetin riboside | 3 |
iGMDRD446 | LY 2183240 | 3 |
iGMDRD375 | GW-405833 | 3 |
iGMDRD466 | Chaetocin | 3 |
Gene in drug-gene network: Network Plot
Gene-drug targets distribution
Gene Structure: PDB
Models in PHF3